The following pages link to Peter P. Lee (Q545620):
Displaying 14 items.
- Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia (Q545621) (← links)
- A theory of immunodominance and adaptive regulation (Q644582) (← links)
- Post-transplantation dynamics of the immune response to chronic myelogenous leukemia (Q776570) (← links)
- Agent-based modeling of the context dependency in T cell recognition (Q776621) (← links)
- Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models (Q941121) (← links)
- A PDE model for imatinib-treated chronic myelogenous leukemia (Q954304) (← links)
- Emergent group dynamics governed by regulatory cells produce a robust primary T cell response (Q977678) (← links)
- Modeling regulation mechanisms in the immune system (Q2210020) (← links)
- A minimal model of T cell avidity may identify subtherapeutic vaccine schedules (Q2240254) (← links)
- Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells (Q2288459) (← links)
- T cell state transition produces an emergent change detector (Q2413785) (← links)
- Stability crossing boundaries of delay systems modeling immune dynamics in leukemia (Q2654524) (← links)
- Basic Principles in Modeling Adaptive Regulation and Immunodominance (Q2820373) (← links)
- A Cellular Automata Model of Early T Cell Recognition (Q5464132) (← links)
